Alignment Healthcare (ALHC) Q4 2023: Membership Surges 37% as Clinical Model Drives Utilization Advantage

February 27, 2024 | By EarningsIQ Research

Alignment Healthcare’s clinically integrated Medicare Advantage model continues to drive above-market member growth and cost control, with the company projecting a 37% increase in membership for 2024. Strategic focus on risk management, STARS quality, and controlled benefit enhancements positions ALHC to capitalize on sector disruption as rivals face reimbursement and regulatory headwinds. Disciplined execution and technology-driven visibility underpin confidence in sustainable margin expansion and market share gains through 2025.

Summary

• Clinical Model Delivers Utilization Edge: Alignment’s care management platform continues to outperform peers on inpatient admissions and cost control.
• Membership Growth Accelerates: Above-market member gains are driven by switching and retention, with churn down 24% during AEP.
• Margin Expansion in Focus: Scaling efficiencies and improved returning member economics set up EBITDA break-even and profitability tailwinds for 2025.

Business Overview

Alignment Healthcare operates as a Medicare Advantage (MA) health plan, providing managed care coverage to seniors, primarily in California, through a clinically integrated model. ALHC generates revenue via capitated payments from the Centers for Medicare & Medicaid Services (CMS) based on membership and risk scores. The business is concentrated in health plan operations, with a legacy ACO REACH value-based care line now de-risked and deprioritized. Key segments include core MA plans, supported by proprietary data analytics and direct care management teams, with a focus on quality (STARS), utilization management, and member engagement.

Performance Analysis

ALHC delivered strong double-digit revenue and membership growth in Q4 and full-year 2023, outpacing initial expectations and industry averages. Membership grew 21% to 119,200 by year-end, and revenue increased 27% to $1.82 billion. The company’s consolidated medical benefit ratio (MBR) remained tightly controlled, with inpatient admissions per thousand running nearly 40% better than traditional Medicare and improving year-over-year. Notably, Q4 inpatient volume declined 7% YoY, underscoring the impact of ALHC’s clinical intervention capabilities.

Adjusted EBITDA was negative for the year, reflecting targeted investments in sales, marketing, and onboarding to capture outsized AEP growth. SG&A leverage improved, with adjusted SG&A as a percentage of revenue falling to 14.4% from 15.9%. The balance sheet remains robust, with $319 million in cash and ample liquidity to fund growth and operational initiatives. ALHC’s 2024 guidance projects further acceleration, with membership expected to reach 162,000–164,000 and revenue climbing to $2.38–$2.41 billion, supported by stable benefits and strong retention.

• Utilization Management Drives Cost Control: Inpatient admissions per thousand fell to 156, outperforming both peers and benchmarks.
• Retention and Switching Fuel Growth: 82% of new AEP sales came from plan switchers, while churn dropped 24% YoY.
• SG&A Efficiency Gains: Operating leverage improved as scaling initiatives and productivity programs took hold.

Management’s disciplined approach to benefit design and risk adjustment, combined with early 2024 utilization trends tracking to plan, supports a confident outlook for margin stability and incremental profitability as the member base matures.

Executive Commentary

Strategic Positioning

1. Clinical Model as Competitive Moat

ALHC’s core advantage is its vertically integrated, data-driven care management platform (AVA), which enables real-time intervention and risk management. By employing clinical teams and leveraging direct data feeds, Alignment achieves tighter control over medical costs and utilization than peers reliant on actuarial or capitation models. This approach consistently delivers lower inpatient admissions and supports best-in-class STARS ratings.

2. Membership Growth and Retention Engine

Alignment’s investments in member experience, STARS, and sales operations have produced outsized membership gains, with churn down 24% and 82% of AEP sales from plan switchers. The company’s stable benefit design and brand momentum, particularly in California, are allowing it to take share as competitors retrench amid regulatory and reimbursement pressure.

3. Margin Expansion through Scale and Cohort Maturation

EBITDA margin expansion is driven by two levers: improved SG&A efficiency as the business scales, and medical cost improvement as new member cohorts mature. Returning members see an average 800 basis point MBR improvement between years one and five, while new members are managed to be gross profit accretive from year one. The company expects these dynamics to accelerate into 2025 as the 2024 cohort matures.

4. De-risking and Refocusing Capital Allocation

ALHC has eliminated downside exposure in its ACO REACH line by moving to a provider capitation arrangement, focusing capital and management attention squarely on Medicare Advantage. This strategic move reduces volatility and simplifies the business model, supporting cleaner financials and more predictable margin delivery.

5. Regulatory and Industry Tailwinds

Alignment’s conservative risk adjustment and durable STARS performance position it to benefit as rivals see reimbursement cuts and regulatory pressure (notably, the impact of V28 and declining competitor STARS ratings). ALHC’s stable benefit design and high-quality delivery are expected to drive further share gains as the market resets.

Key Considerations

This quarter highlights ALHC’s ability to deliver sustainable growth and cost control amid industry turbulence. The company’s differentiated clinical model, disciplined benefit design, and focus on member experience underpin its above-market performance and set the stage for further scale-driven margin gains.

Key Considerations:

• Data-Driven Care Management: AVA technology and clinical teams enable proactive intervention, lowering avoidable admissions and supporting STARS.
• Membership Quality and Mix: Growth is driven by high-retention, high-value members, with new member risk and utilization tracking to bid expectations.
• Benefit Design Discipline: Supplemental benefit value increased just 0.7%, limiting cost creep and protecting margin.
• Scalable Operating Platform: SG&A ratio improvement and workflow automation support break-even EBITDA targets.
• Geographic Concentration: California remains the core market, but the care model is proving exportable to new geographies as scale builds.

Risks

Key risks include regulatory changes to Medicare Advantage reimbursement, competitive reactions as rivals cut benefits or ramp up retention efforts, and execution risk as ALHC scales outside California. While the company’s clinical model has proven resilient, macro policy volatility (including Inflation Reduction Act Part D redesign and V28 risk adjustment) and industry-wide cost pressures could challenge margin stability. Management’s decision to cap downside in ACO REACH limits exposure, but focus will be needed to maintain quality and cost trends as growth accelerates.

Forward Outlook

For Q1 2024, Alignment guided to:

• Health plan membership of 157,000–159,000
• Revenue of $590–$600 million
• Adjusted gross profit of $52–$58 million
• Adjusted EBITDA loss of $13–$19 million

For full-year 2024, management projects:

• Membership of 162,000–164,000
• Revenue of $2.38–$2.41 billion
• Adjusted gross profit of $275–$310 million
• Adjusted EBITDA of negative $15 million to positive $15 million (break-even target)

Management cited strong early retention, stable utilization trends, and robust brand momentum post-AEP as supporting confidence in guidance. Key levers for 2024 include benefit stability, member mix management, and ongoing SG&A efficiency initiatives.

• Stable STARS ratings and conservative risk adjustment underpin revenue visibility.
• Supplemental benefit expense is budgeted as a headwind but tied to improved engagement and retention.

Takeaways

ALHC’s Q4 and full-year results confirm the scalability and defensibility of its clinical care model, with industry-leading cost control and membership growth setting the stage for margin expansion and market share gains.

• Clinical Execution Drives Results: Direct care management and AVA technology yield sustained utilization outperformance and cost discipline, even as the member base grows rapidly.
• Strategic Growth with Margin Discipline: Investments in experience, STARS, and retention are translating into high-quality, profitable growth, with the business on track for EBITDA break-even and further leverage in 2025.
• 2025 Positioned for Outperformance: As new member cohorts mature and industry headwinds intensify for rivals, ALHC’s conservative risk and quality posture should yield incremental share and margin upside.

Conclusion

Alignment Healthcare’s Q4 performance and 2024 outlook underscore the power of a clinically integrated, data-driven MA model in an environment of rising regulatory and cost pressure. With disciplined execution, growing scale, and a proven ability to manage both growth and margin, ALHC is well positioned to extend its advantage as the Medicare Advantage landscape evolves.

Industry Read-Through

ALHC’s results highlight a growing bifurcation in Medicare Advantage, where plans with integrated clinical models, direct risk management, and stable STARS ratings are taking share from legacy players facing reimbursement and regulatory headwinds. The company’s experience in California demonstrates the power of aligned incentives and delegated care, with implications for peers seeking to replicate such models in other geographies. Sector-wide, the pressure to control utilization and manage benefit expense is intensifying, and operators unable to deliver both quality and cost leadership risk margin compression and share loss. ALHC’s approach sets a template for sustainable growth as the MA market resets post-V28 and IRA reforms.

ALHC Healthcare Managed Care Medicare Advantage Clinical Model Membership Growth Utilization Management STARS